Product Description

Recombinant 2019-nCoV NP NTD domain is produced by our E.coli expression system with a 6His tag at the N-terminus.Background:Coronavirus N protein is required for coronavirus RNA synthesis, and has RNA chaperone activity that may be involved in template switch. Nucleocapsid protein is a most abundant protein of coronavirus. N protein packages the positive strand viral genome RNA into a helical ribonucleocapsid (RNP) and plays a fundamental role during virion assembly through its interactions with the viral genome and membrane protein M. Plays an important role in enhancing the efficiency of subgenomic viral RNA transcription as well as viral replication. Because of the conservation of N protein sequence and its strong immunogenicity, the N protein of coronavirus is chosen as a diagnostic tool.Formulation:Supplied as a 0.2 μM filtered solution of PBS, 2M Urea, pH 7.4.Purity:> 95 % as determined by reducing SDS-PAGE.Endotoxin:< 1.0 EU per µg as determined by the LAL method.Shipping:This product is provided as liquid. It is shipped at frozen temperature with blue ice/gel packs. Upon receipt, store it immediately at<-20°C. Avoid freeze-thaw cycles.

More Details:Sequence:N/AFusion Tag:N-6HisAccession:QHD43423.2Species:VirusExpression System:E. coliMol Mass:15.9 kDaAP Mol Mass:16 kDaSynonyms:2019-nCoV coronavirus NP Protein; 2019-nCoV np Protein; 2019-nCoV novel coronavirus Nucleoprotein ProteinDatasheet

FOR RESEARCH USE ONLY, NOT FOR USE IN DIAGNOSTIC PROCEDURES.Manufactured by: Elabscience

"iwaichem公司成立于1947年，主要在日本东京生产和销售高纯试剂，超过60年的经营历史，zui近在生命科学领域销售有大的增长，特别是在诸如分子生物学，基因工程及免疫学。
我们和国内外450家生物技术公司有合作关系，并有70人的销售团队，2500多家研究机构和制药公司客户，iwaichem在日本有1.6亿美金的销售额。"